125 related articles for article (PubMed ID: 2444075)
21. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
22. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
Jaeger N; Vahlensieck W
Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of testicular cancer].
Witjes JA; Debruyne FM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):557-60. PubMed ID: 10321273
[TBL] [Abstract][Full Text] [Related]
25. [Experience in the use of T-activin in patients with malignant testicular tumors and patients with kidney cancer].
Geveling NV; Zhogoleva IB
Vopr Onkol; 1986; 32(8):98-103. PubMed ID: 2429445
[TBL] [Abstract][Full Text] [Related]
26. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
27. [Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy].
Riedinger JM; Eche N; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):515-21. PubMed ID: 18957340
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
[TBL] [Abstract][Full Text] [Related]
29. Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.
Bodrogi I; Baki M; Hindy I; Eckhardt S
Neoplasma; 1983; 30(5):557-61. PubMed ID: 6197662
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
31. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and treatment of germ cell tumors of the ovary].
Sawada M; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2489-95. PubMed ID: 6210050
[TBL] [Abstract][Full Text] [Related]
33. [Preoperative chemotherapy of testicular cancer and Wilm's tumor].
Kawai T
Gan To Kagaku Ryoho; 1985 May; 12(5):1025-30. PubMed ID: 2581512
[TBL] [Abstract][Full Text] [Related]
34. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
[No Abstract] [Full Text] [Related]
35. [Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
Lichinitser MR; Bassalyk LS; Levina DM; Pashintseva LP; Molodyk AA
Ter Arkh; 1984; 56(6):77-9. PubMed ID: 6206585
[No Abstract] [Full Text] [Related]
36. [High-dose chemotherapy with peripheral blood stem cell transplantation as a consolidation therapy for testicular cancer with poor prognosis].
Maruyama F; Ezaki K; Miyazaki H; Iwata M; Kobayashi C; Wakita M; Nomura T; Tsuzuki M; Okamoto M; Matsui T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):297-300. PubMed ID: 7531963
[No Abstract] [Full Text] [Related]
37. [The results of the use of bleomycin and its analogs in the VAB-6 protocol in treating testicular tumors].
Garin AM; Tiuliandin SA; Abdyldaev TA; Khlebnov AV; Kupchan DZ
Antibiot Khimioter; 1988 Nov; 33(11):855-9. PubMed ID: 2465746
[TBL] [Abstract][Full Text] [Related]
38. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
39. [Stage II non-seminoma cancer of the testis: combined treatment with surgery and chemotherapy].
Orlandi L; Van Cauwelaert R; Orlandi F; Vargas R; San Martín S; Arraztoa J
Actas Urol Esp; 1989; 13(1):53-5. PubMed ID: 2469300
[TBL] [Abstract][Full Text] [Related]
40. [Randomized phase III study on nonseminomatous testicular tumor].
Rexer H
Urologe A; 2004 Nov; 43(11):1432-3. PubMed ID: 15526083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
